These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34621796)

  • 1. Inotrope Use and Intensive Care Unit Mortality in Patients With Cardiogenic Shock: An Analysis of a Large Electronic Intensive Care Unit Database.
    Gao F; Zhang Y
    Front Cardiovasc Med; 2021; 8():696138. PubMed ID: 34621796
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Inotropes on the Mortality in Patients With Septic Shock.
    Sato R; Ariyoshi N; Hasegawa D; Crossey E; Hamahata N; Ishihara T; Nasu M; Devendra G
    J Intensive Care Med; 2021 Feb; 36(2):211-219. PubMed ID: 31793373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database.
    Sasmita BR; Wang C; Xie S
    Front Cardiovasc Med; 2023; 10():1300839. PubMed ID: 38094120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early catecholamine dose as a predictor of outcome among patients in a multidisciplinary intensive care unit.
    Agael M; De Vasconcellos K; Skinner D
    S Afr Med J; 2021 Jun; 111(7):674-679. PubMed ID: 34382552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between inotrope treatment and 90-day mortality in patients with septic shock.
    Wilkman E; Kaukonen KM; Pettilä V; Kuitunen A; Varpula M
    Acta Anaesthesiol Scand; 2013 Apr; 57(4):431-42. PubMed ID: 23298252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
    Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-, Clinician-, and Institution-level Variation in Inotrope Use for Cardiac Surgery: A Multicenter Observational Analysis.
    Mathis MR; Janda AM; Kheterpal S; Schonberger RB; Pagani FD; Engoren MC; Mentz GB; Shook DC; Muehlschlegel JD;
    Anesthesiology; 2023 Aug; 139(2):122-141. PubMed ID: 37094103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
    Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
    Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Intraoperative Inhaled Milrinone and Iloprost Reduces Inotrope Use in Patients Undergoing Cardiac Surgery: A Retrospective Cohort Pilot Study.
    Hu X; Li X; Boggett S; Yang Y; Chun-Ting W; Anstey J; Royse A; Royse C
    Anesth Analg; 2020 Aug; 131(2):527-536. PubMed ID: 32371741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
    Di Santo P; Mathew R; Jung RG; Simard T; Skanes S; Mao B; Ramirez FD; Marbach JA; Abdel-Razek O; Motazedian P; Parlow S; Boczar KE; D'Egidio G; Hawken S; Bernick J; Wells GA; Dick A; So DY; Glover C; Russo JJ; McGuinty C; Hibbert B;
    Crit Care; 2021 Aug; 25(1):289. PubMed ID: 34376218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support.
    Nandkeolyar S; Doctorian T; Fraser G; Ryu R; Fearon C; Tryon D; Kagabo W; Abramov D; Hauschild C; Stoletniy L; Hilliard A; Sakr A
    Clin Med Insights Cardiol; 2021; 15():11795468211049449. PubMed ID: 34720602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
    Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
    Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
    Parlow S; Di Santo P; Mathew R; Jung RG; Simard T; Gillmore T; Mao B; Abdel-Razek O; Ramirez FD; Marbach JA; Dick A; Glover C; Russo JJ; Froeschl M; Labinaz M; Fernando SM; Hibbert B;
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):712-720. PubMed ID: 34382063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Karami M; Hemradj VV; Ouweneel DM; den Uil CA; Limpens J; Otterspoor LC; Vlaar AP; Lagrand WK; Henriques JPS
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32629772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of postoperative dobutamine and phosphodiesterase inhibitors after adult elective cardiac surgery and its impact on the length of hospital stay: a post hoc analysis from the multicenter retrospective observational study.
    Yoshida T; Goto A; Shinoda S; Kotani Y; Mihara T;
    Heart Vessels; 2024 May; 39(5):438-445. PubMed ID: 38197915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends and Clinical Outcomes Associated with Vasopressor and Inotrope Use in The Cardiac Intensive Care Unit.
    Jentzer JC; Wiley B; Bennett C; Murphree DH; Keegan MT; Kashani KB; Bell MR; Barsness GW
    Shock; 2020 Apr; 53(4):452-459. PubMed ID: 31169766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.